Loading…
← CockpitCompetitor Analysis › ALX.AX Atlas ArteriaOpen in the cockpit ↗

Atlas ArteriaALX.AXCompetitor analysis, valuation and peers

Australia · AUD·Industrials›Other Transportation

Toll-road investment company owning stakes in motorways in France, the United States and Germany.

≈ A toll-road infrastructure fund like a smaller TransurbanMomentum weak 21
Mkt cap
$3.78B
US dollars, full cap
Free float
31%
of shares outstanding
$/day
$3.58M
20-day average traded
Fwd P/E
20.6×
forward earnings
ROIC−WACC
-7.7 pp
WACC 7.3%
Hurdle
-12 pp
Req g minus delivered
Next earnings
110 days
24 Feb 2027
Close · AUDA$3.75
1D-0.3%
1W+1.1%
1M-2.1%
3M-24.6%
6M-21.4%
YTD-23.2%
1Y-23.9%
ATR %2.7%
52w lowhigh28.4% off high

What Atlas Arteria does

Toll-road investment company owning stakes in motorways in France, the United States and Germany.

Mostly paid by dividends from a minority stake in APRR, France's largest motorway network, which Eiffage controls, so French traffic and toll increases carry the company. French tolls rise by formula each year, and the APRR concession runs to 2035, after which the road returns to the state.

In one line: A toll-road infrastructure fund like a smaller Transurban.

Products and services

  • APRR motorway (France) stake
  • Dulles Greenway (US)
  • Warnow Tunnel (Germany)

Customers

  • Motorway drivers/freight (toll payers)

Where it sits in the supply chain

  • Transport infrastructure
  • Toll road ownership
  • Concession asset management

What could go right

  • Toll escalation (inflation-linked)
  • Traffic volume growth

What could go wrong

  • Concession expiry/renewal risk
  • EV/toll policy or competing-route risk

Moat: wide (regulatory licence, installed base). Long-dated government toll concessions grant exclusive rights on established motorway corridors.

Headquarters: Sydney, Australia · Founded: 2010

Named competitors

Atlas Arteria at a glance

Size Atlas Arteria (ALX.AX) is an Australia Industrials company (Other Transportation) with a market value of $3.78B, the 84th largest of 316 Australia companies the cockpit tracks. Shares closed at A$3.75 on 6 Nov 2026.

Performance Over six months the shares fell 21.4%, against -2.8% for the median peer and +4.1% for the Australia market (cap-weighted) — 5th lowest of 21 in its peer set.

Growth Revenue grew 1.9% over the last twelve months (peer median +6.7%); the operating margin is -19.7% (peer median 16.7%).

Valuation It trades at 20.6× forward earnings against a peer median of 13.9× (4th most expensive of 18).

Price implies For today's price to make sense, revenue must grow about -4% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is -12 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 7.7 points below its cost of capital (7.3% WACC).

Next results Next results expected around 24 Feb 2027 (exchange calendar; dates can move).

Relative performance

809010011 May 202611 Aug 20266 Nov 2026Peer median 97ALX.AX 79
Six months, rebased to 100: Atlas Arteria against the median of its 20 peers (local-currency closes).

Atlas Arteria financials

Reported figures in AUD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueA$157MA$160MA$146MA$134MA$118M
Revenue growth—+10%+9%+13%—
Gross profit-A$6.00MA$13.5MA$22.3MA$16.4MA$116,000
EBITDAA$37.7MA$64.4MA$82.9MA$64.1MA$42.9M
Net incomeA$269MA$260MA$336MA$256MA$241M
Free cash flowA$606MA$613MA$717MA$713MA$473M
Capital expenditureA$200,000A$600,000A$1.10MA$800,000A$357,000
Total debtn/aA$1.72BA$1.85BA$1.72BA$1.74B

Quarterly statements and history in the cockpit →

Atlas Arteria competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%0%+10%WWICAAP6012289706099590416010001199S582633ENAV600004288000058260051560054805766011070009053369ALX.AX6-month return →1-month return →
Up and to the right = strong over both horizons. Atlas Arteria is the large dot.

Fundamentals: revenue growth against valuation

-20%-10%0%+10%+20%0×50×100×WWICAAP9706099590416010001199S58ENAV60000460051560054805763369ALX.AXRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Atlas Arteria is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%WWICAAP970609956010001199S582633ENAV60000428806005483369ALX.AXGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Atlas Arteria is the large dot.

Atlas Arteria competitors and peer comparison

Head to head with its named competitors (ALX.AX vs TCL.AX vs DG.PA vs FER.MC)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Atlas Arteria ALX.AX$3.78B-21%+2%-20%20.6×-3.5%
Transurban TCL.AX$31.6B+1%0%30%84.3×27.8%
Vinci DG.PA$69.8B-12%+4%12%12.2×-1.5%
Ferrovial FER.MC$42.3B-10%+5%10%55.5×21.9%

How Atlas Arteria compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Atlas Arteria against its 20 peers (data as of 6 Nov 2026)
MeasureALX.AXPeer medianRank in peer set
1-month return-2.1%+2.5%4th lowest of 21
6-month return-21.4%-2.8%5th lowest of 21
Distance from 52-week high-28.4%-17.5%5th lowest of 21
Revenue growth (TTM)+1.9%+6.7%8th lowest of 21
Operating margin-19.7%16.7%lowest of 21
Forward P/E20.6×13.9×4th most expensive of 18
Growth the price implies (Req g, 7 yrs)-3.5%-1.2%7th least demanding of 15
Growth delivered (Del g)+8.9%+7.9%7th highest of 15
Hurdle (Req g minus delivered)-12.4 pp-6.5 pp7th least demanding of 15
ROIC minus cost of capital-7.7 pp+0.5 pplowest of 21
Net debt / EBITDA37.0×2.8×most indebted of 10

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Atlas Arteria ALX.AXAustralia$3.78B-21%+2%-20%20.6×-3.5%+8.9%
Wilh. Wilhelmsen WWI.OLNorway$3.87B+23%-4%10%8.4×6.2%+11.0%
Corporacion America Airports CAAPUnited States$4.00B-3%+16%23%9.6×-6.3%+26.4%
Guangzhou Port 601228.SSChina$3.54B-3%-18%11%n/an/an/a
Japan Airport Terminal 9706.TJapan$3.46B+16%+8%17%19.2×-2.3%+40.7%
Anhui Expressway 0995.HKHong Kong$4.18B-3%-17%45%10.5×-5.8%+16.6%
Kintetsu 9041.TJapan$4.23B+5%+2%5%13.5×n/an/a
Tangshan Port 601000.SSChina$4.27B+3%+10%39%13.9×-11.0%-6.2%
COSCO SHIPPING Ports 1199.HKHong Kong$3.32B+18%+12%14%8.5×8.7%+10.9%
SATS S58.SISingapore$4.34B+15%+9%9%17.6×-0.2%+45.6%
Taiwan High Speed Rail 2633.TWTaiwan$4.36B-3%+4%39%19.2×0.8%+6.9%
ENAV ENAV.MIItaly$3.19B+8%+3%9%26.9×13.8%+6.0%
Guangzhou Baiyun International Airport 600004.SSChina$3.18B-6%+9%11%25.2×-12.5%+8.8%
Liaoning Port 2880.HKHong Kong$4.53B-26%+1%21%n/a-9.0%-2.0%
Beibu Gulf Port 000582.SZChina$3.14B-25%-1%21%18.6×n/an/a
Hainan Airport Infrastructure 600515.SSChina$4.56B-26%+25%-5%133.0×n/an/a
Shenzhen Expressway 600548.SSChina$2.99B-4%-5%17%14.4×0.6%+2.9%
Zhejiang Expressway 0576.HKHong Kong$4.86B-13%+18%33%5.9×n/an/a
Sichuan Expressway 601107.SSChina$2.89B+16%+7%27%13.2×n/an/a
Xiamen Port Development 000905.SZChina$2.87B-25%+14%4%n/a4.2%+7.1%
Qinhuangdao Port 3369.HKHong Kong$2.77B+5%+7%23%6.7×-13.2%+2.0%

Questions

Who are Atlas Arteria's main competitors?
Named competitors: Transurban Group (TCL.AX), Vinci (Autoroutes) (DG.PA), Ferrovial (FER.MC). The cockpit's measured peer set (industry) also includes Wilh. Wilhelmsen (WWI.OL), Corporacion America Airports (CAAP), Guangzhou Port (601228.SS), Japan Airport Terminal (9706.T), Anhui Expressway (0995.HK), Kintetsu (9041.T).
Is Atlas Arteria expensive compared with its peers?
On forward p/e it trades at 20.6× against a peer median of 13.9×, 4th most expensive of 18 in its peer set. For today's price to make sense, revenue must grow about -4% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is -12 pp: the price already allows for a slowdown.
How has Atlas Arteria stock performed?
Over six months to 6 Nov 2026 the shares returned -21.4% against -2.8% for the median peer; over one year -23.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.